(R)-(-)-3-Quinuclidinol CAS 25333-42-0 Puritas ≥99.0% Puritas Chiral ≥99.0%

Description:

Chemical Name: (R)-(-)-3-Quinuclidinol

CAS: 25333-42-0

Aspectus: Alba vel Off-White pulveris

Puritas: ≥99.0%

Puritas Chiral: ≥99.0%

Medium API (CAS: 242478-38-2) in curatione vesicae Overactive (Pollakiuria)

Enquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

5

Chemical Properties:

Nomen chemicum (R)-(-)-3-Quinuclidinol
Synonyma (R) -3-Quinuclinol
CAS Number 25333-42-0
CATTUS Number RF-CC117
Stock Status In Stock, Productio Ascendite ad Tons
Formulae hypotheticae C7H13NO
M. Pondus 127.18
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Alba vel Off-White pulveris
Lepidium sativum RT (per GC) Conformare cum Reference Standard
Liquescens punctum 212.0~224.0℃
Imprimis Rotationes [α]D20 -40.0°~ -48.0°
Humor (KF) ≤0.50%
Residere in Ignition ≤0.50%
Puritas ≥99.0%
Totalis immunditias ≤1.00%
Chiral Puritas ≥99.0%
Enantiomer ≤1.00%
Assay 98.0%~101.0% (in Anhydrous Basis)
Test Standard Enterprise Standard
Consuetudinem Chiral Compositions;Pharmaceutical intermedia

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine & humore

commoda:

1

FAQ:

2

Applicatio:

Shanghai Ruifu Chemical Co., Ltd. est primarium fabricae et supplementi (R)-(-)-3-Quinuclidinoli (CAS: 25333-42-0) magna qualitate, late in synthesi organica, synthesi pharmaceuticae intermediorum et Activa Pharmaceutical Ingrediens (API) synthesis.(R)-(-)-3-Quinuclidinol media in synthesi API fieri potest (CAS: 242478-38-2).(CAS: 242478-38-2) medicamentum antimuscarinicum est quod vesicae overactivae tractandae causa signa frequentiae, necessitatis vel incontinentiae adhibetur.(CAS: 242478-38-2) M3 receptor muscarinici hostis est qui enucleatus et emissus est ad curationem vesicae excitativae (pollakiuria) in Europa.M3 receptores in musculi contractiones vesicae lenis fere evocatis implicatae sunt, et receptores M2 etiam suspecti sunt ludi partes ob dominatum in musculo detrusore.Synthesis solifenacinorum involvit praeparationem racemicam 1-Phenyl-1,2,3,4-Tetrahydroisoquinolinam per cyclizationem N-(2-Phenylethyl)benzamidis, et reactionem subsequentem cum ethylo chloroformato et transesterificatione cum (R)-3-Quinuclidinolo. .Chromatographia chiralis praebet solitudinem desiderati diastereomeri.Vel, 1-Phenyl-1,2,3,4-Tetrahydroisoquinolino subjici potest resolutioni optica cum (+) Acido Tartarico priori curationi cum transesterificatione ethylo chloroformato et subsequente.

Epistulam tuam hic scribe et mitte nobis